| 000 | 01527 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513035455.0 | ||
| 264 | 0 | _c19951004 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/87.18.1359 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCook, L S | |
| 245 | 0 | 0 |
_aPopulation-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cSep 1995 |
||
| 300 |
_a1359-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xchemically induced |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 |
_aTamoxifen _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWeiss, N S | |
| 700 | 1 | _aSchwartz, S M | |
| 700 | 1 | _aWhite, E | |
| 700 | 1 | _aMcKnight, B | |
| 700 | 1 | _aMoore, D E | |
| 700 | 1 | _aDaling, J R | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 87 _gno. 18 _gp. 1359-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/87.18.1359 _zAvailable from publisher's website |
| 999 |
_c7657927 _d7657927 |
||